REDWOOD CITY, Calif., Feb. 24, 2011 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS) today announced that David Anton, Ph.D. has been promoted to Chief Technology Officer and Senior Vice President, Process Development and Manufacturing, a new position. He will continue to report to Alan Shaw, Ph.D., President and Chief Executive Officer.
Dr. Anton joined Codexis in 2008 after a 25-year career with DuPont. He served as Vice President, Research and Development for Codexis Bioindustrials from 2008-09, and Senior Vice President, Research and Development from 2009-11.
"Under Dave Anton's leadership, Codexis R&D has grown to an organization that today is developing commercial products and processes in four global markets – biofuels, pharmaceuticals, carbon capture and biobased chemicals," Dr. Shaw said. "His nearly three decades of experience in technology development and commercialization – including commercial scale-up and manufacturing - will be important as we continue our transition to a product company."
Dr. Anton joined DuPont in 1983, and held a variety of senior research management positions across bioprocessing and biocatalysis. He led the process research, development and commercialization of several products, including 1,3 propanediol (a chemical intermediate used in a variety of industrial applications ranging from airplane deicing fluids to textiles and carpet). As Vice President, Research and Development for DuPont's joint venture with Tate and Lyle, he directed technology start-up activities for the first 100 million-pound plant for 1,3 propanediol, commissioned in Loudon, TN in 2006. As Venture Manager, Biofuels, he was global business lead for development of DuPont's advanced biofuel, biobutanol.
He holds a bachelor's degree in biochemistry from the University of California, Berkeley, and a Ph.D. in bioch
|SOURCE Codexis, Inc.|
Copyright©2010 PR Newswire.
All rights reserved